HBIO news

Latest 1 stories · newest Nov 10, 2026

HBIO

HBIO Q3 2026 Revenue Grows 8% to $22.2 Million

Harvard Bioscience Inc reported third-quarter revenue of $22.2 million, up 8% year-over-year. The company reaffirmed full-year 2026 revenue growth guidance of 3-5% and reported an adjusted EBITDA of $1.8 million.

Earnings|Guidance Nov 10, 2026 sentiment -0.05 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same HBIO feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/HBIO/newsSTART FREE